In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Novadaq FOPO nets $55mm

Executive Summary

Novadaq Technologies Inc. netted $55mm through the public sale of 4.5mm common shares (including the overallotment) at $12.90 apiece. The company sells its SPY line of fluorescence devices, which allow for real-time imaging during interventional surgical procedures without exposing patients to radiation.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register